Doncaster CCG MMT Review of Montelukast in asthma patients under 18 years. – Background BNFC Montelukast doses are assigned to specific Rationale for review:- It was highlighted by a clinician that some patients’ montelukast were not being increased in line with their age. This review will assist clinicians to ensure safe, effective prescribing and provide evidence of review.
Doncaster CCG MMT – Review of Montelukast in asthma patients under 18 years. Background BNFC Montelukast doses are assigned to specific Rationale for review:- It was highlighted by a clinician that some patients’ montelukast were not being increased in line with their age. This review will assist clinicians to ensure safe, effective prescribing and provide evidence of review.
Review-of-Montelukast-in-asthma-patients-under-18-years-V1-0.docx